Reversible cerebral vasoconstriction syndrome associated with interferon beta-1a use for multiple sclerosis.
Reversible cerebral vasoconstriction syndrome (RCVS) has been associated with multiple medications, cocaine, pregnancy, migraine, and other conditions. RCVS associated with interferon beta use has never before been described. We describe the case of a 20-year-old female who developed acute onset severe headache and was found to have subarachnoid hemorrhage 2 months after initiating Rebif (Interferon beta-1a) for multiple sclerosis (MS). Cerebral angiography showed multiple areas of distal stenosis and dilatation with radiographic resolution 1 month later. This is the first case report of RCVS in an MS patient treated with Rebif.